# INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

> **NCT03071328** · EARLY_PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 10 (actual)

## Conditions studied

- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Metastatic Urothelial Carcinoma
- Metastatic Renal Cell Carcinoma

## Interventions

- **DRUG:** Isovue-M 200

## Key facts

- **NCT ID:** NCT03071328
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-08
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-04-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03071328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03071328, "INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03071328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*